Table 1.
Characteristics | Number of patients, n (%) |
Mean age, yr (range) | 71.1 (30-86) |
Gender | |
Male | 49 (63.6) |
Female | 28 (36.4) |
Depth of invasion | |
T1 | 28 (36.4) |
T2 | 25 (32.5) |
T3 | 21 (27.3) |
T4 | 3 (3.9) |
Lymph node metastasis | |
N0 | 34 (44.2) |
N1 | 14 (18.2) |
N2 | 13 (16.9) |
N3 | 16 (20.8) |
Histological type | |
Well-differentiated adenocarcinoma | 42 (54.5) |
Poorly-differentiated adenocarcinoma | 29 (46.9) |
Signet-ring cell carcinoma | 1 (1.3) |
Carcinoma with lymphoid stroma | 3 (3.9) |
Mucinous adenocarcinoma | 1 (1.3) |
Endocrine carcinoma | 1 (1.3) |
Stage of disease | |
I | 29 (37.7) |
II | 23 (29.9) |
III | 12 (15.6) |
IV | 13 (16.9) |
H. pylori infection (IgG titer) | |
Negative (< 20 U/mL) | 17 (22.1) |
Positive (≥ 20 U/mL) | 60 (77.9) |
PGI | |
≤ 70 ng/mL | 76 (98.7) |
> 70 ng/mL | 1 (1.3) |
PG I/PG II | |
≤ 3 | 64 (83.1) |
> 3 | 13 (16.9) |
PG method | |
Positive (PG I ≤ 70 and PG I/II ≤ 3) | 63 (81.8) |
Negative (except the cases described above) | 14 (18.2) |
ABCD stratification (H. pylori infection/PG method) | |
A (negative/negative) | 3 (3.9) |
B (positive/negative) | 11 (14.3) |
C (positive/positive) | 49 (63.6) |
D (negative/positive) | 14 (18.2) |
KK-LC-1 | |
Positive | 63 (81.8) |
Negative | 14 (18.2) |
Positive of H. pylori infection; IgG titer ≥ 20 U/mL, Positive of PG method; PG I ≤ 70 ng/mL and PG I/PG II ≤ 3. KK-LC-1: Kita–Kyushu lung cancer antigen-1; H. pylori: Helicobacter pylori.